Funding for collaborative research on new treatments for mental disorders, substance use disorders, and alcohol use disorder, emphasizing novel drugs/devices and industry-academic partnerships.
Funding available for research on innovative drug and device treatments for mental disorders, substance use, and alcohol use, promoting collaboration between academia and industry through U01 mechanism.
This grant funds early stage trials of new drugs and neuromodulatory devices for psychiatric disorders, aiming to de-risk and attract further funding.
NIH supports exploratory, phased clinical research on the neurobiological mechanisms of substance use disorders, including relevant circuitry and behavior; clinical trials are optional.
This grant supports developing advanced brain stimulation devices for treating mental health disorders, focusing on novel techniques and significant improvements to existing FDA-approved devices.
Supports preclinical and clinical research to develop interventions to prevent or treat substance use disorders and overdose, advancing candidates toward regulatory approval or clinical adoption.